Rhode Island Chronicle

In Vitro Fertilization Market: Opportunities and Challenges

 Breaking News
  • No posts were found

In Vitro Fertilization Market: Opportunities and Challenges

November 09
18:04 2019
In Vitro Fertilization Market: Opportunities and Challenges

The major players in the in vitro fertilization market include CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US).
Asia is one of the most preferred destinations for medical care. One of the major factors driving the medical tourism industry in Asia is the low cost for high-quality healthcare facilities delivered by doctors and surgeons trained and educated in the top institutes in the US and Europe.

In Vitro Fertilization Market and its key opportunities and challenges

The global In Vitro Fertilization Market is projected to be valued at USD 465.2 Million in 2016 and is expected to grow at a CAGR of 10.9% from 2017 to reach to USD 847.8 Million by 2022, as per a report by MarketsandMarkets. 

How growing fertility tourism offers an opportunity?

Asia is one of the most preferred destinations for medical care. One of the major factors driving the medical tourism industry in Asia is the low cost for high-quality healthcare facilities delivered by doctors and surgeons trained and educated in the top institutes in the US and Europe.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891

According to a survey conducted by the IFFS in 2013, there are more than 600 IVF clinics across India. In addition to the availability of advanced healthcare facilities, the cost of an IVF cycle in India is around 70% lower than that in some developed countries. According to the ASRM, an average IVF cycle in the US costs around USD 12,400, whereas the costs drop dramatically to USD 3,000 in India and USD 4,000 in Thailand. Thus, the low cost of the procedure and quality healthcare facilities in the Asian countries will create growth opportunities for the IVF market in the region.

Why reducing efficacy of infertility treatment with advancing age is a challenge?

The changing social scenario has resulted in an increasing number of older women seeking help from infertility clinics. As a woman ages, it takes her longer to conceive, and the chances of not being able to conceive also increase. Also, the risk of miscarriage and complications in pregnancy and childbirth increases with age.

According to the ASRM, a 30-year-old healthy and fertile woman has about a 20% chance of getting pregnant without assistance every month, whereas for a woman aged 40 years or above, the chance decreases to 5%. Furthermore, for a woman aged 30 years, approximately 40% of IVF cycles results in live births, whereas the success rate reduces to 20% for women older than 40 years. A woman aged 35 years or above is 2.5 times more prone to have a miscarriage or stillbirth than a woman aged less than 35 years; whereas, a woman aged above 40 years is more than five times prone to have a miscarriage or stillbirth than a woman under 35 years of age.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=89198891

Browse Related Reports:

Preimplantation Genetic Testing Market by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application (Aneuploidy, Translocations), End User (Fertility Clinics, Research) – Forecast to 2022

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) – Forecasts to 2023

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/in-vitro-fertilization-market-89198891.html